Tuesday, May 21, 2024


Dhaka Tribune

Bangladesh approves emergency use of Moderna Covid-19 vaccine

The country is set to receive 2.5 million doses of Moderna vaccine from the US

Update : 29 Jun 2021, 11:32 PM

The health authorities in Bangladesh have approved the Moderna Covid-19 vaccine for emergency use in the country.

The Directorate General of Drug Administration (DGDA) gave the approval on Tuesday, according to a press release.

This is the eighth vaccine to receive emergency use authorization from the DGDA.

The vaccine can be administered among people aged 18 and above. The two-dose vaccine will be inoculated within four weeks of the first jab.

The vaccine's preservation temperature ranges between 15°C and 25°C.

The approval comes as the US began shipping 2.5 million doses of Moderna vaccine to Bangladesh on Tuesday, a White House official told AFP.

Also Read - Moderna's Covid-19 vaccine shows promise against Delta variant in lab study

Bangladesh started a pilot vaccination program on January 27 and the nationwide program on February 7 by administering Covishield, the Oxford-AstraZeneca Covid-19 vaccine manufactured by the Serum Institute of India (SII).

However, on April 25, the government suspended administering the first dose of the vaccine, just a day after India stopped exporting the vaccine due to the record-breaking surge in cases and deaths there.

As the SII could not provide the doses of vaccine, a good number of people around Bangladesh are still waiting for their second jabs.

Also Read - US sending Bangladesh 2.5 million Covid vaccine doses

However, on June 1, Bangladesh received the first consignment of 100,620 doses of the Pfizer-BioNTech Covid-19 vaccine, under the Covax scheme run by WHO and Gavi, the Vaccine Alliance.

Meanwhile, China also sent 1.1 million doses of the Sinopharm vaccine to Bangladesh as a special gift in two shipments.

The country is also negotiating with Russia to buy its Sputnik V vaccine.

Top Brokers


Popular Links